What is NDC 0409-6727?

0409-6727 is the product NDC for Magnesium Sulfate in Dextrose, Magnesium sulfate heptahydrate 10 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Magnesium sulfate heptahydrate.

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Magnesium Sulfate in Dextrose?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Magnesium Sulfate in Dextrose NDC 0409-6727

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-6727Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-6727Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-6727-23	0040967272300409672723	24 POUCH in 1 CASE (0409-6727-23) / 1 BAG in 1 POUCH / 100 mL in 1 BAG (0409-6727-11)Marketed from Sep 27, 2005
0409-6727-24	0040967272400409672724	24 POUCH in 1 CASE (0409-6727-24) / 1 BAG in 1 POUCH / 100 mL in 1 BAG (0409-6727-55)Marketed from Aug 24, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Magnesium Sulfate in Dextrose
Generic name (nonproprietary): magnesium sulfate in dextrose
Active ingredients: Magnesium sulfate heptahydrate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020488
Marketing start: Sep 27, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0409-6727_f2a7493f-f459-4f67-b1c5-c17514c85353SPL ID f2a7493f-f459-4f67-b1c5-c17514c85353SPL set ID 03ebeabb-8386-4af4-3086-bdf3c3fc4a5aRxCUI 829757UNII SK47B8698T
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409672723 followed by a unit qualifier and the quantity

Package 00409-6727-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 24, 2026.

Indications (excerpt from the label)

Magnesium Sulfate in 5% Dextrose Injection is indicated for: • Prevention of eclampsia in patients with preeclampsia • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia Magnesium Sulfate in 5% Dextrose Injection is indicated for ( 1 ): • Prevention of eclampsia in patients with preeclampsia ( 1 ) • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-6727

What is NDC 0409-6727?: 0409-6727 is the product NDC for Magnesium Sulfate in Dextrose, Magnesium sulfate heptahydrate 10 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Magnesium Sulfate in Dextrose.
What is the active ingredient?: Magnesium sulfate heptahydrate.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Magnesium Sulfate in Dextrose?: 3 other product NDCs are listed under this name. See all Magnesium Sulfate in Dextrose NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Magnesium Sulfate in Dextrose NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Magnesium Sulfate in Dextrosemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 10 mg/mL	Injection, SolutionIntravenous	B. Braun Medical Inc.	0264-4400	00264-4400-54
Magnesium Sulfate In Dextrose	Magnesium sulfate heptahydrate 10 mg/mL	Injection, SolutionIntravenous	Baxter Healthcare Corporation	0338-1709	00338-1709-40
Magnesium Sulfate in Dextrosemagnesium sulfate	Magnesium sulfate heptahydrate 1 g/100mL	InjectionIntravenous	WG Critical Care, LLC	44567-410	44567-0410-24